Advertisement

Biochemistry (Moscow)

, Volume 82, Issue 1, pp 75–80 | Cite as

Cancer: Bad luck or punishment?

  • A. V. LichtensteinEmail author
Discussion

Abstract

Contrasting opinions on the role of extrinsic and intrinsic factors in cancer etiology (Tomasetti, C., and Vogelstein, B. (2015) Science, 347, 78-81; Wu, S., et al. (2016) Nature, 529, 43-47) variously define priorities in the war on cancer. The correlation between the lifetime risk of several types of cancer and the total number of divisions of normal selfrenewing cells revealed by the authors has given them grounds to put forward the “bad luck” hypothesis. It assumes that ~70% of cancer variability is attributed to random errors arising during DNA replication in normal, noncancerous stem cells, i.e. to internal factors, which is impossible either to expect or to prevent. This assumption caused many critical responses that emphasize, on the contrary, the defining role of extrinsic factors in cancer etiology. The analysis of epidemio-logical and genetic data presented in this work testifies in favor of the “bad luck” hypothesis.

Keywords

cancer bad luck hypothesis carcinogenesis mutagenesis extrinsic and intrinsic causes of cancer cancer prevention 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zaridze, D. G. (2008) Molecular epidemiology of cancer, Biochemistry (Moscow), 73, 532–542.CrossRefGoogle Scholar
  2. 2.
    Tomasetti, C., and Vogelstein, B. (2015) Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions, Science, 347, 78–81.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Gotay, C., Dummer, T., and Spinelli, J. (2015) Cancer risk: prevention is crucial, Science, 347, 728.CrossRefPubMedGoogle Scholar
  4. 4.
    Ashford, N. A., Bauman, P., Brown, H. S., Clapp, R. W., Finkel, A. M., Gee, D., Hattis, D. B., Martuzzi, M., Sasco, A. J., and Sass, J. B. (2015) Cancer risk: role of environment, Science, 347, 727.CrossRefPubMedGoogle Scholar
  5. 5.
    Potter, J. D., and Prentice, R. L. (2015) Cancer risk: tumors excluded, Science, 347, 727.CrossRefPubMedGoogle Scholar
  6. 6.
    O’Callaghan, M. (2015) Cancer risk: accuracy of literature, Science, 347, 729.CrossRefPubMedGoogle Scholar
  7. 7.
    Song, M., and Giovannucci, E. L. (2015) Cancer risk: many factors contribute, Science, 347, 728–729.CrossRefPubMedGoogle Scholar
  8. 8.
    Wild, C., Brennan, P., Plummer, M., Bray, F., Straif, K., and Zavadil, J. (2015) Cancer risk: role of chance overstated, Science, 347, 728.CrossRefPubMedGoogle Scholar
  9. 9.
    Tarabichi, M., and Detours, V. (2015) Comment on “Variation in cancer risk among tissues can be explained by the number of stem cell divisions”, BioRxiv, doi: http://dx. doi. org/10.1101/024497.Google Scholar
  10. 10.
    Ledford, H. (2015) Cancer studies clash over mechanisms of malignancy, Nature, 528, 317.CrossRefPubMedGoogle Scholar
  11. 11.
    Albini, A., Cavuto, S., Apolone, G., and Noonan, D. M. (2015) Strategies to prevent “bad luck” in cancer, J. Natl. Cancer Inst., 107, doi: 10.1093/jnci/djv213.Google Scholar
  12. 12.
    Wu, S., Powers, S., Zhu, W., and Hannun, Y. A. (2016) Substantial contribution of extrinsic risk factors to cancer development, Nature, 529, 43–47.CrossRefPubMedGoogle Scholar
  13. 13.
    Rozhok, A. I., Wahl, G. M., and DeGregori, J. (2015) A critical examination of the “bad luck” explanation of cancer risk, Cancer Prev. Res (Phil.), 8, 762–764.CrossRefGoogle Scholar
  14. 14.
    Siegel, R., Ma, J., Zou, Z., and Jemal, A. (2014) Cancer statistics, 2014, Cancer J. Clin., 64, 9–29.Google Scholar
  15. 15.
    Ahmad, A. S., Ormiston-Smith, N., and Sasieni, P. D. (2015) Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960, Br. J. Cancer, 112, 943–947.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Bray, F., Jemal, A., Grey, N., Ferlay, J., and Forman, D. (2012) Global cancer transitions according to the Human Development Index (2008-2030): a population-based study, Lancet Oncol., 13, 790–801.CrossRefPubMedGoogle Scholar
  17. 17.
    Esserman, L. J., Thompson, I. M., and Reid, B. (2013) Overdiagnosis and overtreatment in cancer: an opportunity for improvement, JAMA, 310, 797–798.CrossRefPubMedGoogle Scholar
  18. 18.
    Oke, J. L., Nicholson, B. D., and Shinkins, B. (2015) Comment on: “Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960”–cancer predictions need more context, Br. J. Cancer, 113, 1632.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Shimizu, H., Ross, R. K., Bernstein, L., Yatani, R., Henderson, B. E., and Mack, T. M. (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County, Br. J. Cancer, 63, 963–966.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Greaves, M. (2014) Does everyone develop covert cancer? Nat. Rev. Cancer, 14, 209–210.CrossRefPubMedGoogle Scholar
  21. 21.
    Anisimov, V. N., Ukraintseva, S. V., and Yashin, A. I. (2005) Cancer in rodents: does it tell us about cancer in humans? Nat. Rev. Cancer, 5, 807–819.CrossRefPubMedGoogle Scholar
  22. 22.
    Lobo, V., Patil, A., Phatak, A., and Chandra, N. (2010) Free radicals, antioxidants and functional foods: impact on human health, Pharmacogn. Rev., 4, 118–126.PubMedGoogle Scholar
  23. 23.
    Holmgren, L., Szeles, A., Rajnavolgyi, E., Folkman, J., Klein, G., Ernberg, I., and Falk, K. I. (1999) Horizontal transfer of DNA by the uptake of apoptotic bodies, Blood, 93, 3956–3963.PubMedGoogle Scholar
  24. 24.
    Trejo-Becerril, C., Perez-Cardenas, E., Taja-Chayeb, L., Anker, P., Herrera-Goepfert, R., Medina-Velazquez, L. A., HidalgoMiranda, A., Perez-Montiel, D., Chavez-Blanco, A., CruzVelazquez, J., Diaz-Chavez, J., Gaxiola, M., and DuenasGonzalez, A. (2012) Cancer progression mediated by horizontal gene transfer in an in vivo model, PLoS One, 7, e52754.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Martincorena, I., and Campbell, P. J. (2015) Somatic mutation in cancer and normal cells, Science, 349, 1483–1489.CrossRefPubMedGoogle Scholar
  26. 26.
    Abu-Remaileh, M., Bender, S., Raddatz, G., Ansari, I., Cohen, D., Gutekunst, J., Musch, T., Linhart, H., Breiling, A., Pikarsky, E., Bergman, Y., and Lyko, F. (2015) Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer, Cancer Res., 75, 2120–2130.CrossRefPubMedGoogle Scholar
  27. 27.
    Forment, J. V., Kaidi, A., and Jackson, S. P. (2012) Chromothripsis and cancer: causes and consequences of chromosome shattering, Nat. Rev. Cancer, 12, 663–670.CrossRefPubMedGoogle Scholar
  28. 28.
    Baca, S. C., Prandi, D., Lawrence, M. S., Mosquera, J. M., Romanel, A., Drier, Y., Park, K., Kitabayashi, N., MacDonald, T. Y., Ghandi, M., Van, A. E., Kryukov, G. V., Sboner, A., Theurillat, J. P., Soong, T. D., Nickerson, E., Auclair, D., Tewari, A., Beltran, H., Onofrio, R. C., Boysen, G., Guiducci, C., Barbieri, C. E., Cibulskis, K., Sivachenko, A., Carter, S. L., Saksena, G., Voet, D., Ramos, A. H., Winckler, W., Cipicchio, M., Ardlie, K., Kantoff, P. W., Berger, M. F., Gabriel, S. B., Golub, T. R., Meyerson, M., Lander, E. S., Elemento, O., Getz, G., Demichelis, F., Rubin, M. A., and Garraway, L. A. (2013) Punctuated evolution of prostate cancer genomes, Cell, 153, 666–677.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Bunting, S. F., and Nussenzweig, A. (2013) End-joining, translocations and cancer, Nat. Rev. Cancer, 13, 443–454.CrossRefGoogle Scholar
  30. 30.
    Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., McLaren, S., Lin, M. L., McBride, D. J., Varela, I., Nik-Zainal, S., Leroy, C., Jia, M., Menzies, A., Butler, A. P., Teague, J. W., Quail, M. A., Burton, J., Swerdlow, H., Carter, N. P., Morsberger, L. A., IacobuzioDonahue, C., Follows, G. A., Green, A. R., Flanagan, A. M., Stratton, M. R., Futreal, P. A., and Campbell, P. J. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development, Cell, 144, 27–40.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Iskow, R. C., McCabe, M. T., Mills, R. E., Torene, S., Pittard, W. S., Neuwald, A. F., Van Meir, E. G., Vertino, P. M., and Devine, S. E. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons, Cell, 141, 1253–1261.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Doucet-O’Hare, T. T., Rodic, N., Sharma, R., Darbari, I., Abril, G., Choi, J. A., Young, A. J., Cheng, Y., Anders, R. A., Burns, K. H., Meltzer, S. J., and Kazazian, H. H. (2015) LINE-1 expression and retrotransposition in Barrett’s esophagus and esophageal carcinoma, Proc. Natl. Acad. Sci. USA, 112, E4894–E4900.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ewing, A. D., Gacita, A., Wood, L. D., Ma, F., Xing, D., Kim, M. S., Manda, S. S., Abril, G., Pereira, G., Makohon-Moore, A., Looijenga, L. H., Gillis, A. J., Hruban, R. H., Anders, R. A., Romans, K. E., Pandey, A., Iacobuzio-Donahue, C. A., Vogelstein, B., Kinzler, K. W., Kazazian, H. H., and Solyom, S. (2015) Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution, Genome Res., 25, 1536–1545.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Rodic, N., Steranka, J. P., Makohon-Moore, A., Moyer, A., Shen, P., Sharma, R., Kohutek, Z. A., Huang, C. R., Ahn, D., Mita, P., Taylor, M. S., Barker, N. J., Hruban, R. H., Iacobuzio-Donahue, C. A., Boeke, J. D., and Burns, K. H. (2015) Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma, Nat. Med., 21, 1060–1064.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Swanton, C., McGranahan, N., Starrett, G. J., and Harris, R. S. (2015) APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity, Cancer Discov., 5, 704–712.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Folkman, J., and Kalluri, R. (2004) Cancer without disease, Nature, 427, 787.CrossRefPubMedGoogle Scholar
  37. 37.
    Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., Bignell, G. R., Bolli, N., Borg, A., Borresen-Dale, A. L., Boyault, S., Burkhardt, B., Butler, A. P., Caldas, C., Davies, H. R., Desmedt, C., Eils, R., Eyfjord, J. E., Foekens, J. A., Greaves, M., Hosoda, F., Hutter, B., Ilicic, T., Imbeaud, S., Imielinsk, M., Jager, N., Jones, D. T. W., Jones, D., Knappskog, S., Kool, M., Lakhani, S. R., Lopez-Otin, C., Martin, S., Munshi, N. C., Nakamura, H., Northcott, P. A., Pajic, M., Papaemmanuil, E., Paradiso, A., Pearson, J. V., Puente, X. S., Raine, K., Ramakrishna, M., Richardson, A. L., Richter, J., Rosenstiel, P., Schlesner, M., Schumacher, T. N., Span, P. N., Teague, J. W., Totoki, Y., Tutt, A. N. J., Valdes-Mas, R., Van Buuren, M. M., Veer, L., VincentSalomon, A., Waddell, N., Yates, L. R., Australian Pancreatic Cancer Genome Initiative, ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain ICGC, Zucman-Rossi, J., Andrew Futreal, P., McDermott, U., Lichter, P., Meyerson, M., Grimmond, S. M., Siebert, R., Campo, E., Shibata, T., Pfister, S. M., Campbell, P. J., and Stratton, M. R. (2013) Signatures of mutational processes in human cancer, Nature, 500, 415–421.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Alexandrov, L. B. (2015) Understanding the origins of human cancer, Science, 350, 1175–1177.CrossRefPubMedGoogle Scholar
  39. 39.
    Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik-Zainal, S., and Stratton, M. R. (2015) Clock-like mutational processes in human somatic cells, Nat. Genet., 47, 1402–1407.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Nik-Zainal, S., Alexandrov, L., Wedge, D., VanTaLoo, P., Greenman, C., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L., Menzies, A., Martin, S., Leung, K., Chen, L., Leroy, C., Ramakrishna, M., Rance, R., Lau, K., Mudie, L., Varela, I., McBride, D., Bignell, G., Cooke, S., Shlien, A., Gamble, J., Whitmore, I., Maddison, M., Tarpey, P., Davies, H., Papaemmanuil, E., Stephens, P., McLaren, S., Butler, A., Teague, J., Jonsson, G., Garber, J., Silver, D., Miron, P., Fatima, A., Boyault, S., Langerod, A., Tutt, A., Martens, J., Aparicio, S., Borg, A., Salomon, A., Thomas, G., BorresenDale, A. L., Richardson, A., Neuberger, M., Futreal, P. T., Campbell, P., and Stratton, M. (2012) Mutational processes molding the genomes of 21 breast cancers, Cell, 149, 979–993.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Tomasetti, C., and Vogelstein, B. (2015) Cancer risk: role of environment-response, Science, 347, 729–731.CrossRefPubMedGoogle Scholar
  42. 42.
    Zaridze, D. G., Mukeriya, A. F., and Shan’gina, O. V. (2016) Interaction of environmental factors and genetic polymorphism in the etiology of cancer, Adv. Mol. Oncol., 3, 8–17.CrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2017

Authors and Affiliations

  1. 1.Institute of CarcinogenesisBlokhin Cancer Research CenterMoscowRussia

Personalised recommendations